Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Pulmonary Hypertension in Schistosomiasis: An Overview

Ghazwan Butrous


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Release Date: 05.03.2013

Presentation Type: Webinars

Global Impact of PHSchistosomiasis is the third leading endemic parasitic disease in the world. Worldwide, 200-300 million individuals are infected. Current evidence shows that infection with Schistosomiasis increases the chances of developing PH. The current burden of disease assumes that there may be as many as 15 million people living with Schistosomiasis-Associated PH.

International expert Dr. Ghazwan Butrous discusses the burden of disease caused by schistosomiasis which affects 200-300 million people worldwide.  An additional burden to healthcare systems in the developing world are the complications due to this disease which affect the pulmonary vascular system. Evidence shows that an estimated 2-10% of patients with schistosomiasis may suffer from pulmonary hypertension.  What can be done to raise awareness about this disease worldwide? What can be done for these patients once pulmonary hypertension develops?
 
Learning Objectives

At the conclusion of this live activity, attendees will be able to:
  1. Describe the global impact of Schistosomiasis
  2. Explain the role of Schistosomiasis in inducing pulmonary hypertension
  3. Discuss the global effort to study this pathological condition